Omega-3 fatty acids in the management of autism spectrum disorders: findings from an open-label pilot study in Singapore

The goal of this open-label trial was to examine the efficacy and safety of a 12-week omega-3 fatty acids supplementation among children suffering with Autism Spectrum Disorders (ASD). A total of 41 children and adolescents aged 7–18 years (36 boys, 5 girls; mean age=11.66, s.d.=3.05) diagnosed with...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	European journal of clinical nutrition 2015-08, Vol.69 (8), p.969-971
Hauptverfasser:	Ooi, Y P, Weng, S-J, Jang, L Y, Low, L, Seah, J, Teo, S, Ang, R P, Lim, C G, Liew, A, Fung, D S, Sung, M
Format:	Artikel
Sprache:	eng
Schlagworte:	692/699/476 692/700/565 Adolescent Adolescents Attention Autism Autism Spectrum Disorder - blood Autism Spectrum Disorder - drug therapy Autism Spectrum Disorder - psychology Behavior Rating Scale Blood Blood levels Care and treatment Child Children Clinical Nutrition Clinical trials Dietary Supplements Disorders Epidemiology Fatty acids Fatty Acids - blood Fatty Acids, Omega-3 - therapeutic use Female Health aspects Humans Internal Medicine Male Medicine Medicine & Public Health Metabolic Diseases Nutrition Omega 3 fatty acids Pilot Projects Public Health short-communication Side effects Signs and symptoms Singapore Supplements Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The goal of this open-label trial was to examine the efficacy and safety of a 12-week omega-3 fatty acids supplementation among children suffering with Autism Spectrum Disorders (ASD). A total of 41 children and adolescents aged 7–18 years (36 boys, 5 girls; mean age=11.66, s.d.=3.05) diagnosed with ASD participated in the study. At post-treatment, participants showed significant improvements on all subscales of the Social Responsiveness Scale ( P
ISSN:	0954-3007 1476-5640
DOI:	10.1038/ejcn.2015.28